Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.
复制标题
DOI:
10.1016/j.ccr.2010.01.021
复制
发表时间:
2010-03-16
期刊:
影响因子:
50.3
通讯作者:
Ruggero D
中科院分区:
文献类型:
--
作者:
Hsieh AC;Costa M;Zollo O;Davis C;Feldman ME;Testa JR;Meyuhas O;Shokat KM;Ruggero D
We genetically dissect the contribution of the most prominent downstream translational components of mTOR signaling toward Akt-driven lymphomagenesis. While phosphorylation of rpS6 is dispensable for cancer formation, 4EBP-eIF4E exerts significant control over cap-dependent translation, cell growth, cancer initiation, and progression. This effect is mediated at least in part through 4EBP-dependent control of Mcl-1 expression, a key antiapoptotic protein. By using an active site inhibitor of mTOR, PP242, we show a marked therapeutic response in rapamycin-resistant tumors. The therapeutic benefit of PP242 is mediated through inhibition of mTORC1-dependent 4EBP-eIF4E hyperactivation. Thus, the 4EBP-eIF4E axis downstream of mTOR is a druggable mediator of translational control and Akt-mediated tumorigenesis that has important implications for the treatment of human cancers.
登录
查看更多内容
DOI:
10.1073/pnas.231467698
发表时间:
2001-12-18
影响因子:
11.1
作者:
Malstrom, S;Tili, E;Tsichlis, PN
通讯作者:
Tsichlis, PN
影响因子:
5.3
作者:
Mothe-Satney, I;Yang, DQ;Lawrence, JC
通讯作者:
Lawrence, JC
影响因子:
7.3
作者:
Guertin, David A.;Sabatini, David M.
通讯作者:
Sabatini, David M.
影响因子:
8
作者:
Mende, I;Malstrom, S;Aoki, M
通讯作者:
Aoki, M
影响因子:
64.8
作者:
Barna, Maria;Pusic, Aya;Zollo, Ornella;Costa, Maria;Kondrashov, Nadya;Rego, Eduardo;Rao, Pulivarthi H.;Ruggero, Davide
通讯作者:
Ruggero, Davide